Fri, September 29, 2017
Thu, September 28, 2017
Wed, September 27, 2017
Tue, September 26, 2017
Mon, September 25, 2017
Fri, September 22, 2017
Thu, September 21, 2017
Wed, September 20, 2017
Tue, September 19, 2017
Mon, September 18, 2017
Fri, September 15, 2017
Thu, September 14, 2017
Wed, September 13, 2017
Tue, September 12, 2017
Mon, September 11, 2017
Fri, September 8, 2017
Thu, September 7, 2017
Wed, September 6, 2017
Tue, September 5, 2017
Fri, September 1, 2017
Thu, August 31, 2017
Wed, August 30, 2017

Kennen MacKay Initiated (AGIO) at Buy and Held Target at $78 on, Sep 15th, 2017


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-78-on-sep-15th-2017.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Kennen MacKay of RBC Capital, Initiated "Agios Pharmaceuticals, Inc." (AGIO) at Buy and Held Target at $78 on, Sep 15th, 2017.

Kennen has made no other calls on AGIO in the last 4 months.



There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 1 agrees with Kennen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Debjit Chattopadhyay of "Janney Montgomery Scott" Downgraded from Strong Buy to Hold on, Monday, June 26th, 2017


This is the rating of the analyst that currently disagrees with Kennen


  • Michael Schmidt of "Leerink Swann" Upgraded from Hold to Buy on, Wednesday, August 2nd, 2017

Publication Contributing Sources